Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture: Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes

Journal of Clinical Investigation

Volumn 95, Issue 1, 1995, Pages 317-327

  Bata Csorgo, Zsuzsanna ^a   Hammerberg, Craig ^a   Voorhees, John J ^a   Cooper, Kevin D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Flow cytometry; Keratin 1 keratin 10; Proliferating cell nuclear antigen; 1 integrin; IFN

Indexed keywords

CD3 ANTIGEN; CYCLINE; FIBRONECTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTEGRIN; INTERLEUKIN 3; INTERLEUKIN 4; KERATIN; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CYCLE G0 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; STEM CELL; T LYMPHOCYTE;

ANTIGENS, CD29; ANTIGENS, CD4; ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELLS, CULTURED; CLONE CELLS; EPIDERMIS; FLOW CYTOMETRY; HUMAN; INTEGRINS; KERATINOCYTES; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MELANOCYTES; PROLIFERATING CELL NUCLEAR ANTIGEN; PSORIASIS; SKIN; STEM CELLS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0028842377     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117659     Document Type: Article

References (59)

1. Jones, P. H., and F. M. Watt. 1993. Separation of human epidermal stem cells from transit amplifying cells on the basts of differences in integrin function and expression. Cell. 73:713-724.
2. Cotsarelis, G., S.-Z. Cheng, G. Dong, T.-T, Sun, and R. M. Lavker. 1989. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 57:201-209.
3. Watt, F. M. 1988. Epidermal stem cells in culture. J. Cell Sci. Suppl. 10:85-94.
4. Bata-Csorgo, Zs., C. Hammerberg, S. J. Voorhees, and K. D. Cooper. 1993. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J. Exp. Med. 178:1271-1281.
5. Cairnie, A. B., P. K. Lala, and D. G. Osmond. 1976. Stem Cells of Renewing Cell Populations. Academic Press, Inc., Orlando, FL.
6. Lavker, R. M., and T.-T. Sun. 1982. Heterogeneity in epidermal basal keratinocytes: Morphological and functional correlations. Science (Wash. DC). 215:1239-1241.
7. Lavker, R. M., and T.-T. Sun. 1983. Epidermal stem cells. J. Invest. Dermatol. 81:121s-127s.
8. Christophers, E., R. Parzefall, and O. Braun-Falco. 1973. Initial events in psoriasis: quantitative assessment. Br. J. Dermatol. 89:327-334.
9. Braun-Falco, O., and C. Schmoeckel. 1977. The dermal inflammatory reaction in initial psoriatic lesions. Arch. Dermatol. Res. 258:9-16.
10. Gupta, A. K., O. Baadsgaard, C. N. Ellis, J. J. Voorhees, and K. D. Cooper. 1989. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch. Dermatol. Res. 281:219-226.
11. Stingl, G., K. Wolff, E. Diem, G. Baumgartner, and W. Knapp. 1977. In situ identification of lymphoreticular cells in benign and malignant infiltrates by membrane receptor sites. J. Invest. Dermatol. 69:231-235.
12. Placek, W., M. Haftek, and J. Thivolet. 1988. Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Dermato-Venereol. (Stockh.). 68:369-377.
13. Baker, B. S., A. F. Swain, L. Fry, and H. Valdimarsson. 1984. Epidermal T lymphocyles and HLA-DR expression in psoriasis. Br. J. Dermatol. 110:555-564.
14. Bos, J. D., H. J. Hulsebosch, S. R. Krieg, P. M. Bakker, and R. H. Cormane. 1983. Immunocompetent cells in psoriasis: in situ immunopnenotyping by monoclonal antibodies. Arch. Dermatol. Res. 275:181-189.
15. Morganroth, G. S., L. S. Chan, G. D. Weinstein, J. J. Voorhees, and K. D. Cooper. 1991. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa + perivascular dendritic cells. J. Invest. Dermatol. 96:333-340.
16. Uyemura, K., M. Yamatnura, D. F. Fivenson, R. L. Modlin, and B. J. Nickoloff. 1993. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type I cell-mediated response. J. Invest. Dermatol. 101:701-705.
17. Ellis, C. N., D. C. Gorsulowsky, T. A. Hamilton, J. K. Billings, M. D. Brown, J. T. Headington, K. D. Cooper, O. Baadsgaard, E. A. Duell, T. M. Annesley, et al. 1986. Cyclosporine improves psoriasis in a double-blind study. JAMA (J. Am. Med. Assoc.). 256:3110-3116.
18. Nicolas, J.-F., N. Chamchick, J. Thivolet, J. Wijdenes, P. Morel, and J. P. Revillard, 1991. CD4 antibody treatment of severe psoriasis [letter]. Lancet. 338:321.
19. Weinshenker, B. G., B. H. Bass, G. C. Ebers, and G. P. A. Rice. 1989. Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatment. J. Am. Acad. Dermatol. 20:1132-1133.
20. Prinz, J., O. Braun-Falco, M. Meurer, P. Daddona, C. Reiter, P. Rieber, and G. Riethmuller. 1991. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet. 338:320-321.
21. Poizot-Martin, I., C. Dhiver, C. Mawas, D. Olive, and J. A. Gastaut. 1991. Are CD4 antibodies and peptide T new treatments for psoriasis? [letter]. Lancet. 337:1477.
22. Ackerman, C., K. Abu-Elagd, K. Venkataramanan, J. Fung, S. Todo, T. Starzl, and B. Jegasothy. 1991. Recalcitrant psoriasis and pyoderma gangrenosum treated with FK506. J. Invest. Dermatol. 96:536. (Abstr.)
23. Morhenn, V. B., E. A. Abel, and G. Mahrle. 1982. Expression of HLA-DR antigen in skin from patients with psoriasis. J. Invest. Dermatol. 78:165-168.
24. Gottlieb, A. B., A. D. Luster, D. N. Posnett, and D. M. Carter. 1988. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168:941-948.
25. Singer, K. H., D. T. Tuck, H. A. Sampson, and R. P. Hall. 1989. Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J. Invest. Dermatol. 92:746-750.
26. Baadsgaard, O., A. K. Gupta, R. S. Taylor, C. N. Ellis, J. J. Voorhees, and K. D. Cooper. 1989. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J. Invest. Dermatol. 92:190-195.
27. Griffiths, C. E. M., J. J. Voorhees, and B. J. Nickoloff. 1989. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J. Am. Acad. Dermatol. 20:617-629.
28. Schlaak, J. F., M. Buslau, W. Jochum, E. Hermann, M. Girndt, H. Gallati, K.-H. Buschenfelde, and B. Fleischer. 1994. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102:145-149.
29. Baadsgaard, O., P. Tong, J. T. Elder, E. R. Hansen, V. Ho, C. Hammerberg, G. Lange-Vejlsgaard, D. A. Fox, G. Fisher, et al. 1990. UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J. Invest. Dermatol. 95:275-282.
30. Strange, P., K. D. Cooper, E. R. Hansen, G. Fisher, J. K. Larsen, D. Fox, C. Krag, J. J. Voorhees, and O. Baadsgaard. 1993. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J. Invest. Dermatol. 101:695-700.
31. De Luca, M., G. Pellegrini, S. Bondanza, O. Cremona, P. Savoia, R. Cancedda, and P. C. Marchisio. 1992. The control of polarized integrin topography and the organization of adhesion-related cytoskeleton in normal human keratinocytes depend upon number of passages in culture and ionic environment. Exp. Cell Res. 202:142-150.
32. Marcelo, C. L., E. A. Duell, L. M. Rhodes, and W. R. Dunham. 1992. In vitro model of essential fatty acid deficiency. J. Invest. Dermatol. 99:703-708.
33. Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, D. N. Sauder, J. J. Voorhees, and G. Fisher. 1990. IL-1 activity is reduced in psoriatic skin: decreased IL-1 alpha and increased non-functional IL-1 beta. J. Immunol. 144:4593-4603.
34. Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, R. S. Taylor, J. J. Voorhees, and G. Fisher. 1990. Interleukin-1 in human skin: dysregulation in psoriasis. J. Invest. Dermatol. 95:24S-26S.
35. Potten, C. S., and R. J. Morris. 1988. Epithelial stem cells in vivo. J. Cell Sci. Suppl. 10:45-62.
36. Chang, E. Y., C. Hammerberg, G. Fisher, O. Baadsgaard, C. N. Ellis, J. J. Voorhees, and K. D. Cooper. 1992. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch. Dermatol. 128:1479-1485.
37. Barrandon, Y., and H. Green. 1985. Cell size as a determinant of the clone-forming ability of human keratinocytes. Proc. Natl. Acad. Sci. USA. 82:5390-5394.
38. Kaplan, G., G. Walsh, L. S. Guido, P. Meyn, R. A. Burkhardt, R. M. Abalos, J. Barker, P. A. Frindt, T. T. Fajardo, R. Celona, and Z. A. Cohn. 1992. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 175:1717-1728.
39. Hofbauer, R., and D. T. Denhardt. 1991. Cell cycle-regulated and proliferation stimulus-responsive genes. Crit. Rev. Eukaryotic Gene Expression. 1:247-300.
40. Kurki, P., M. Vanderlaan, F. Dolbeare, J. Gray, and E. M. Tan. 1986. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp. Cell Res. 166:209-219.
41. Watt, F. M., and P. H. Jones. 1994. Human epidermal stem cells. J. Cell. Biochem. Suppl. 18B:173. (Abstr.)
42. Rytina, E., and F. M. Watt. 1994. Lineage analysis in cultured human keratinocytes. J. Cell. Biochem. Suppl. 18B:188. (Abstr.)
43. Zambruno, G., G. Girolomoni, M.-J. Staquet, D. Schmitt, and A. Giannetti. 1988. CDw29 expression on Langerhans cells and on basal keratinocytes. In The Langerhans Cell. J. Thivolet and D. Schmitt, editors. John Libbey & Company Ltd./London. 159-165.
44. Zambruno, G., V. Manca, M. L. Santantonio, D. Soligo, and A. Giannetti. 1991. VLA protein expression on epidermal cells (keratinocytes, Langerhans cells, melanocytes): a light and electron microscopic immunohistochemical study. Br. J. Dermatol. 124:135-145.
45. Dover, R., and N. A. Wright. 1991. The Cell Proliferation Kinetics of the Epidermis. In Physiology, Biochemistry, and Molecular Biology of the Skin. L. A. Goldsmith, editor. Oxford University Press, New York. 239-265.
46. Morris, R. J., and C. S. Potten. 1994. Slow cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Proliferation. 27:279-289.
47. Hancock, G. E., G. Kaplan, and Z. A. Cohn. 1988. Keratinocyte growth regulation by the products of immune cells. J. Exp. Med. 168:1395-1402.
48. Nickoloff, B. J., R. S. Mitra, J. T. Elder, G. J. Fisher, and J. J. Voorhees. 1989. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br. J. Dermatol. 121:161-174.
49. Baker, B. S., A. V. Powles, H. Valdimarsson, and L. Fry. 1988. An altered response by psoriatic keratinocytes to gamma interferon. Scand. J. Immunol. 28:735-740.
50. Volc-Platzer, B., P. Valent, T. Radaszkiewicz, P. Mayer, P. Bettelheim, and K. Wolff. 1991. Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivo. Lab. Invest. 64:557-566.
51. Smith, C. H., R. W. Groves, E. L. Ross, J. N. W. N. Barker, and D. M. MacDonald. 1993. Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on Langerhans cells in vivo. J. Invest. Dermatol. 100:490. (Abstr.)
52. Schwartz, M., S. Braunstein, G. Kaplan, Z. Cohn, A. B. Gottlieb, and J. G. Krueger. 1993. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Dermatol. 100:494. (Abstr.)
53. Nickoloff, B. J., T. Y. Basham, T. C. Merigan, and V. B. Morhenn. 1984. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. Lab. Invest. 51:697-701.
54. Fierlbeck, G., G. Rassner, and C. Muller. 1990. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch. Dermatol. 126:351-355.
55. Caux, C., I. Moreau, S. Saeland, and J. Banchereau. 1992. Interteron-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood. 79:2628-2636.
56. Morhenn, V. B. 1988. Keratinocyte proliferation in wound healing and skin diseases. Immunol. Today. 9:104-107.
57. Kaplan, G., M. D. Witmer, I. Nath, R. M. Steinman, S. Laal, H. K. Prasad, E. N. Sarno, U. Elvers, and Z. A. Cohn. 1986. Influence of delayed immune reactions on human epidermal keratinocytes. Proc. Natl. Acad. Sci. USA. 83:3469-3473.
58. Kaplan, G., A. Nusrat, E. N. Sarno, C. K. Job, J. McElrath, J. A. Porto, C. I. Nathan, and Z. A. Cohn. 1987. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am. J. Pathol. 128:345-353.
59. Baker, B. S., A. V. Powles, S. Lambert, H. Valdimarsson, and L. Fry. 1988. A prospective study of the Koebner reaction and T lymphocytes in uninvolved psoriatic skin. Acta Dermato-Venereol. (Stockh.). 68:430-434.